Alexander Li

Title: Innovations and Contributions of Inventor Alexander Li

Introduction

Alexander Li is a prominent inventor based in White Plains, NY (US), known for his significant contributions to the field of biotechnology. With a total of 7 patents, he has made remarkable strides in developing innovative solutions for medical challenges.

Latest Patents

Among his latest patents is the invention titled "17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof." This invention focuses on double-stranded ribonucleic acid (dsRNA) compositions that target the HSD17B13 gene. It includes methods for inhibiting the expression of HSD17B13 and treating subjects with HSD17B13-associated diseases, disorders, or conditions. Another notable patent is related to "Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists." This patent provides methods for treating individuals with skin cancer or those at risk of developing it, as well as identifying subjects with an increased risk of skin cancer.

Career Highlights

Alexander Li is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research and development in the field of pharmaceuticals. His expertise and innovative mindset have contributed to the advancement of medical treatments and therapies.

Collaborations

Throughout his career, Alexander has collaborated with esteemed colleagues, including Aris I Baras and Noura S Abul-Husn. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

In summary, Alexander Li is a distinguished inventor whose work has greatly impacted the biotechnology sector. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.